ARMEN GARO H 4
4 · AGENUS INC · Filed Jun 2, 2026
Research Summary
AI-generated summary of this filing
Agenus (AGEN) CEO Garo H. Armen Receives 4,644-Share Award
What Happened Garo H. Armen, Chairman, Chief Executive Officer and Principal Financial Officer of Agenus (AGEN), received 4,644 shares of common stock as compensation for the pay period ending May 29, 2026. The shares were issued at the closing price of $3.50 on May 29, 2026, for a total value of $16,254. The issuance was an award/stock-for-salary transaction and the shares were fully vested on the date of issuance.
Key Details
- Transaction date: May 29, 2026; Form 4 filed June 2, 2026 (filed within the normal two-business-day window).
- Transaction type/code: Award/acquisition (A) — shares issued in lieu of cash salary.
- Price/value: $3.50 per share (closing price on May 29, 2026); total value ~$16,254.
- Shares held after transaction: Not explicitly stated in the filing. Footnotes disclose related holdings: 23,950 shares in the Garo Armen 2020 2-Year AG GRAT (Dr. Armen is trustee and has investment authority) and 5,000 shares held by Pixie Partners (a partnership in which he is a general partner); shares from this issuance are held in Dr. Armen’s IRA accounts.
- Notable footnotes: (F1) salary paid in stock with Compensation Committee approval; shares fully vested on issuance. (F2) price based on closing market price. (F3) shares held in IRA. (F4) disclosures about GRAT and Pixie holdings and a disclaimer of beneficial ownership to the extent of pecuniary interest.
Context This was a compensation-issued stock award (not an open-market purchase or sale). Such stock-for-salary issuances are routine forms of executive compensation and do not by themselves indicate insider buying or selling sentiment. The filing appears timely under Form 4 rules.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-05-29$3.50/sh+4,644$16,254→ 355,967 total
- 31,298(indirect: See Footnote)
Common Stock
[F3] - 28,950(indirect: See Footnote)
Common Stock
[F4]
Footnotes (4)
- [F1]At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending May 29, 2026. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.
- [F2]$3.50 is the closing price of our Common Stock on May 29, 2026, the last trading day for the payroll date for the pay period ending May 29, 2026.
- [F3]Shares are held in Dr. Armen's IRA accounts.
- [F4]Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.